Option Care Health, Inc. filings document the public-company disclosures of a Nasdaq-listed provider of home and alternate-site infusion services. Its common stock is registered under the symbol OPCH, and its regulatory record includes Current Reports on Form 8-K, proxy materials, and exhibits tied to operating results and corporate actions.
OPCH filings cover quarterly and annual financial results, non-GAAP measure reconciliations, Regulation FD investor presentations, amendments to its first lien credit agreement, executive officer changes and related severance matters, and definitive proxy disclosures. The proxy record addresses board governance, stockholder voting matters, executive compensation, and capital allocation context for the company's infusion services business.
Option Care Health director Norman L. Wright purchased 3,411 shares of OPCH common stock on 09/09/2025 at a weighted average price of $29.3099 per share, with individual purchase prices ranging from $29.28 to $29.31. After the transactions, the reporting person beneficially owned 15,501 shares. The Form 4 was signed by Michael Shapiro as attorney-in-fact on 09/10/2025. No derivative securities were reported in this filing.
Pate R. Carter, a director of Option Care Health, Inc. (OPCH), reported purchasing 750 shares of the company's common stock on 08/20/2025 at a weighted average price of $27.1886 per share. After the reported purchase the filing shows the reporting person beneficially owns 41,910 shares. The transaction is coded "P" (purchase). The explanatory note states the 750 shares were bought in multiple transactions with prices ranging from $27.18 to $27.1899, and the reporter will provide detailed per-trade quantities and prices upon request. The Form 4 was signed on behalf of Mr. Carter by an attorney-in-fact.
Option Care Health director Harry M. Kraemer Jr. purchased 36,000 shares of common stock on 08/20/2025 at a weighted average price of $27.1466 per share, increasing his direct beneficial ownership to 375,390 shares. The Form 4 reports the purchases were executed in multiple transactions with individual prices ranging from $26.92 to $27.20 per share, and notes the reporting person will provide detailed allocation information upon request. The filing identifies Mr. Kraemer as a director and indicates the transaction code as "P" for purchase.
Option Care Health director Timothy P. Sullivan reported an open-market purchase of common stock on 08/21/2025. The Form 4 shows a purchase (transaction code P) of 20,000 shares at $27.51 per share, bringing his beneficial ownership to 49,229 shares, held directly. The filing was signed on behalf of Mr. Sullivan by an attorney-in-fact, Michael Shapiro.
Insider purchase disclosed: Option Care Health director David W. Golding acquired 1,000 shares of the company's common stock on 08/21/2025 at a price of $27.625 per share. After the purchase, Mr. Golding beneficially owned 116,525 shares, held directly. The Form 4 was signed on behalf of Mr. Golding by attorney-in-fact Michael Shapiro.
Option Care Health, Inc. filed a Current Report on Form 8-K that attaches an Employment Offer Letter dated August 19, 2025 between the company and Meenal A. Sethna, and a Transition Agreement and Release dated August 19, 2025 between Option Care Enterprises, Inc. and Michael Shapiro. The filing also includes a Press Release dated August 20, 2025 as an exhibit and the cover page formatted in Inline XBRL. The report is signed on behalf of the company by Michael Shapiro, Chief Financial Officer on August 20, 2025.
Option Care Health, Inc. (OPCH) Chief Accounting Officer Nicole Maggio reported an acquisition of common stock via a restricted stock unit award. The Form 4 records a transaction dated 08/06/2025 for 7,167 restricted stock units granted at a reported price of $0, bringing her reported beneficial ownership to 26,476 shares.
The filing identifies the transaction as an acquisition (code "A") and direct ownership. The restricted stock units are disclosed to vest in full on 08/06/2027. No derivative securities or disposals are listed in Table II of the form, and the filing contains an explanatory note that the award vests in full on the stated date.